Navigation Links
DePuy ASR Settlement News: Bernstein Liebhard LLP Notes Appointment of Special Masters, Claims Administrator to Oversee Proposed DePuy ASR Lawsuit Settlement
Date:11/24/2013

New York, New York (PRWEB) November 24, 2013

Preparations have begun for the proposed settlement of thousands of DePuy ASR lawsuit (http://www.depuy-asr-hip-recall.com/) claims filed in the wake of the 2012 DePuy ASR hip recall, Bernstein Liebhard LLP reports. According to court documents filed in U.S. District Court, Northern District of Ohio on November 22nd, the parties have appointed a Claims Administrator, as well as Special Masters, to oversee the DePuy ASR settlement process. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“We are continuing to evaluate the proposed settlement program to determine how best to advise our DePuy ASR lawsuit clients. At the same time, our Firm continues to investigate claims on behalf of individuals who were affected by the DePuy ASR recall, but who do not meet eligibility requirements for the settlement, ” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who allegedly experienced metallosis, chronic pain, disability, premature hip implant failure, and other serious complications allegedly related to devices included in the DePuy ASR recall.

DePuy ASR Settlement Proposal
According to court documents, the DePuy ASR settlement proposal was announced in the Northern District of Ohio on November 19th. The New York Times has reported that if the accord is accepted by 94% of eligible plaintiffs, the $2.5 billion settlement would resolve roughly 8,000 of the 12,000 claims currently pending against Johnson & Johnson and its DePuy Orthopaedics unit. *

According to information released by DePuy Orthopaedics following the announcement of the agreement, the settlement will apply only to recipients of the recalled hip implants who underwent revision surgery to replace the device prior to August 31, 2013. Those plaintiffs would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience “certain extraordinary injuries” in the future.**

According to Bloomberg.com, the DePuy ASR recall was issued after data indicated that 12% of the metal-on-metal hips were failing within just five years of implantation. However, more recent data indicates that the actual early failure rate associated with the devices could reach as high as 44%.***

Individuals who were affected by the DePuy ASR recall, but who are not eligible to participate in the proposed settlement program, may still be entitled to file their own lawsuit seeking compensation for their alleged injuries. To learn more about filing a DePuy ASR lawsuit, please visit Bernstein Liebhard LLP’s Website. To arrange for a free, no-obligation legal review, please call 800-511-5092.

*nytimes.com/2013/11/20/business/johnson-johnson-to-offer-2-5-billion-hip-device-settlement.html, New York Times, November 20, 2013
**usasrhipsettlement.com/Un-Secure/Docs/Settlement_Program_Overview_Final.pdf, DePuy Orthopaedics, November 19, 2013.
***bloomberg.com/news/2013-11-19/j-j-unveils-hip-accord-that-may-be-worth-more-than-4-bln.html, Bloomberg.com, November 19, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.depuy-asr-hip-recall.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-asr-settlement/prweb11365234.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy ASR Lawsuit Settlement News: Johnson & Johnson Deal Still Leaves Opportunity to File Lawsuits, Notes Rottenstein Law Group LLP
2. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of Remand Hearings for Federal Pinnacle Hip Lawsuits
3. DePuy ASR Lawsuit Settlement Excludes Many Individuals Who May Have Been Harmed by Devices Included in DePuy ASR Recall, Bernstein Liebhard LLP Reports
4. DrugRisk Adds Latest Court Update on DePuy Hip Lawsuits
5. DePuy ASR Lawsuit Settlement News: Bernstein Liebhard LLP Comments on Announcement of DePuy ASR Recall Settlement
6. $2.5 Billion Settlement In DePuy ASR Hip Replacement Lawsuits, Reports Wright & Schulte LLC
7. DePuy Settlement Update: Nov. 19 Conference Could Involve ASR Hip Settlement Talks, Rottenstein Law Group LLP Reports
8. US Drug Watchdog Now Urges Recipients Of The Recalled DePuy ASR Hip Implant To Call Them About A Just Announced Settlement If They Are Not Yet Represented By Counsel
9. $4 Billion DePuy ASR Hip Recall Lawsuit Settlement Reportedly Agreed to by Johnson & Johnson Reports Wright & Schulte LLC
10. DePuy ASR Settlement Update: Rottenstein Law Group LLP Comments on $4 Billion DePuy Hip Settlement News
11. Case List Grows Rapidly in Federal DePuy Pinnacle Lawsuit Litigation, as Bernstein Liebhard LLP Notes Over 5,200 Cases Now Filed over All-Metal Hip
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: